Market Overview

According to fortune business insights, the global cell culture supplements market size was valued at USD 3.08 billion in 2025. The market is projected to grow from USD 3.34 billion in 2026 to USD 6.17 billion by 2034, exhibiting a CAGR of 7.98% during the forecast period. North America dominated the global cell culture supplements market with a market share of 42.86% in 2025.

The analysis shows that these supplements enhance cell growth, viability, and productivity in laboratory and industrial settings. The market is driven by increasing demand for biologics, personalized medicine, and advancements in cell-based therapies, along with rising research activities spurred by the prevalence of chronic diseases.

Major Players Profiled in the Market Report:

• Thermo Fisher Scientific Inc. (U.S.)
• Merck KGaA (Germany)
• Cytiva (U.S.)
• Sartorius AG (Germany)
• Corning Incorporated (U.S.)
• Bio-Techne (U.S.)
• STEMCELL Technologies (Canada)
• FUJIFILM Biosciences (U.S.)
• HiMedia Laboratories (India)
• BD (U.S.)

Segments

Strategic Activities to Propel Serum & Serum-Derived Supplements Segment Growth

Based on product type, the market is categorized into serum & serum-derived supplements, growth factors & cytokines, lipids, fatty acids & cholesterol supplements, and others. The serum & serum-derived supplements segment holds the largest market share owing to the widespread use of additives like fetal bovine serum and rising strategic initiatives by key players to boost product sales.

Proven Effectiveness to Drive Animal-derived Segment Expansion

By source, the market is segmented into animal-derived, recombinant, synthetic, microbial-derived, and others. The animal-derived segment is leading the market due to its widespread availability, proven effectiveness in supporting cell growth, and established use in both research and biopharmaceutical production.

Increasing R&D to Drive Drug Discovery & Development Segment Dominance